Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management.
about
Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study.Tissue-advanced glycation end product concentration in dialysis patients.Cardiac evaluation prior to kidney transplantationHomocystein as a risk factor for developing complications in chronic renal failure.Mortality in hemodialysis patients over 65 years of agePredictors of Arrhythmic Events Detected by Implantable Loop Recorders in Renal Transplant Candidates.Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial.Association between circulating endothelial cells and carotid atherosclerosis in patients receiving maintenance hemodialysis.Circulating endothelial cells and chronic kidney disease.Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem.Neurohumoral activity, heart failure and prognosis in patients with end-stage renal disease treated by hemodialysis.Seasonal variation of C-reactive protein and atherosclerotic cardiovascular events in hemodialysis patients.Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology?Relation between exhaled nitric oxide and left ventricular performance in chronic hemodialysis patients.Change in cardiovascular disease status in peritoneal dialysis patients: a 5-year single-center experience.The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney disease.
P2860
Q24531203-05FDD5C9-9888-4273-A5BE-46DC59F61B76Q31120569-2A0ADB13-9727-4BD2-9159-1732C1CE524EQ33571288-788A2B68-4E47-448C-AFB7-03A8D91CA856Q34009695-2C992A19-C6C8-4B8E-A846-BC474E5796F1Q35507954-4858B2E2-0C19-4442-90CC-6D8FE972B8EBQ35508302-C5CF41C2-E329-4C20-AF2D-654EB7B8082FQ36295799-01757873-6049-4C48-A6EF-5E27154D2C86Q36432925-A17318C7-FA0A-40C9-9F84-5B0C04D2DDB0Q37688069-CD5258EA-97FD-4EB8-9E27-C138182ECE10Q38221884-EF2CB19B-881B-4D99-8C30-ABC0512A0198Q38671493-1A6B7C89-7B2A-4E74-8361-449E7EB946B3Q44392374-D7B1C380-6776-41B8-9FF7-B522FEDEB4AEQ44439514-C62E355B-76EC-4C6F-B6C9-0252123AA4BCQ44494762-3A08238F-91FC-483F-9BF9-37A4E0D1D75EQ45132558-5F02F164-FFDA-48F5-9671-9F6C56440B75Q50991537-AA914941-A8F7-442A-8F22-C76B69D28812Q55709403-F71718D7-7198-4393-996C-A13588B9CE14
P2860
Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cardiac disease in dialysis pa ...... , risk factors and management.
@ast
Cardiac disease in dialysis pa ...... , risk factors and management.
@en
Cardiac disease in dialysis pa ...... , risk factors and management.
@nl
type
label
Cardiac disease in dialysis pa ...... , risk factors and management.
@ast
Cardiac disease in dialysis pa ...... , risk factors and management.
@en
Cardiac disease in dialysis pa ...... , risk factors and management.
@nl
prefLabel
Cardiac disease in dialysis pa ...... , risk factors and management.
@ast
Cardiac disease in dialysis pa ...... , risk factors and management.
@en
Cardiac disease in dialysis pa ...... , risk factors and management.
@nl
P356
P1476
Cardiac disease in dialysis pa ...... , risk factors and management.
@en
P2093
Parfrey PS
P356
10.1093/NDT/15.SUPPL_5.58
P407
P478
15 Suppl 5
P577
2000-01-01T00:00:00Z